UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer

Molecular cancer therapeutics, 2014-04, Vol.13 (4), p.890-901

2014

Volltextzugriff (PDF)

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome

Cancer research (Chicago, Ill.), 2007-07, Vol.67 (13), p.6383-6391

2007

Volltextzugriff (PDF)

Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3028-3038

2009

Volltextzugriff (PDF)

Large Competitive Kinetic Isotope Effects in Human 15-Lipoxygenase Catalysis Measured by a Novel HPLC Method

Journal of the American Chemical Society, 1999-02, Vol.121 (6), p.1395-1396

1999

Volltextzugriff (PDF)

A Point Mutation Leads to Altered Product Specificity in β -lactamase Catalysis

Proceedings of the National Academy of Sciences - PNAS, 1997-01, Vol.94 (2), p.443-447

1997

Volltextzugriff (PDF)

Site-Directed Mutagenesis of Glutamate-166 in .beta.-Lactamase Leads to a Branched Path Mechanism

Biochemistry (Easton), 1994-06, Vol.33 (24), p.7619-7626

1994

Volltextzugriff (PDF)

N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Journal of medicinal chemistry, 2001-10, Vol.44 (22), p.3750-3753

2001

Volltextzugriff (PDF)

Enzyme-Induced Strain/Distortion in the Ground-State ES Complex in β-Lactamase Catalysis Revealed by FTIR

Biochemistry (Easton), 2000-05, Vol.39 (21), p.6538-6545

2000

Volltextzugriff (PDF)

Abstract 1416: CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1416-1416

2014

Volltextzugriff (PDF)

Abstract 966: Novel pharmacodynamic assays to measure glutaminase inhibition following oral administration of CB-839

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.966-966

2014

Volltextzugriff (PDF)

Metabolism, Disposition and Pharmacokinetics of PR-171, a Novel Inhibitor of the 20S Proteasome

Blood, 2006-11, Vol.108 (11), p.5067-5067

2006

Volltextzugriff (PDF)

A Pyrolysis Product, Anhydroecgonine Methyl Ester (Methylecgonidine), is in the Urine of Cocaine Smokers

Journal of analytical toxicology, 1990-11, Vol.14 (6), p.353-357

1990

Volltextzugriff (PDF)

Pharmacologic Evaluation of Orally Bioavailable Inhibitors of the 20S Proteasome

Blood, 2006-11, Vol.108 (11), p.3581-3581

2006

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics and Anti-Tumor Efficacy of PR-171, a Novel Inhibitor of the 20S Proteasome

Blood, 2005-11, Vol.106 (11), p.609-609

2005

Volltextzugriff (PDF)

Electrical isolation of dislocations in Ge layers on Si(001) substrates through CMOS-compatible suspended structures

Science and technology of advanced materials, 2012-10, Vol.13 (5), p.055002-055002

2012

Volltextzugriff (PDF)

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

Cell, 2016-01, Vol.164 (3), p.433-446

2016

Volltextzugriff (PDF)

A CLEAR AGE-VELOCITY DISPERSION CORRELATION IN ANDROMEDA'S STELLAR DISK

The Astrophysical journal, 2015-04, Vol.803 (1), p.1-17

2015

Volltextzugriff (PDF)

Segmental duplications and their variation in a complete human genome

Science (American Association for the Advancement of Science), 2022-04, Vol.376 (6588), p.eabj6965-eabj6965

2022

Volltextzugriff (PDF)

Chemobiosis reveals tardigrade tun formation is dependent on reversible cysteine oxidation

PloS one, 2024-01, Vol.19 (1), p.e0295062-e0295062

2024

Volltextzugriff (PDF)

A rogues gallery of Andromeda’s dwarf galaxies – II. Precise distances to 17 faint satellites

Monthly notices of the Royal Astronomical Society, 2019-10, Vol.489 (1), p.763-770

2019

Volltextzugriff (PDF)

Comparing the Quenching Times of Faint M31 and Milky Way Satellite Galaxies

Astrophysical journal. Letters, 2019-11, Vol.885 (1), p.L8

2019

Volltextzugriff (PDF)

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma

Pancreas, 2016-03, Vol.45 (3), p.370-375

2016

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Journals - AutoHoldings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(281)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome

Design and Synthesis of an Orally Bioavailable and Selective Peptide Epoxyketone Proteasome Inhibitor (PR-047)

Large Competitive Kinetic Isotope Effects in Human 15-Lipoxygenase Catalysis Measured by a Novel HPLC Method

A Point Mutation Leads to Altered Product Specificity in β -lactamase Catalysis

Site-Directed Mutagenesis of Glutamate-166 in .beta.-Lactamase Leads to a Branched Path Mechanism

N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Enzyme-Induced Strain/Distortion in the Ground-State ES Complex in β-Lactamase Catalysis Revealed by FTIR

Abstract 1416: CB-839, a novel potent and selective glutaminase inhibitor, has broad antiproliferative activity in cell lines derived from both solid tumors and hematological malignancies

Abstract 966: Novel pharmacodynamic assays to measure glutaminase inhibition following oral administration of CB-839

Metabolism, Disposition and Pharmacokinetics of PR-171, a Novel Inhibitor of the 20S Proteasome

A Pyrolysis Product, Anhydroecgonine Methyl Ester (Methylecgonidine), is in the Urine of Cocaine Smokers

Pharmacologic Evaluation of Orally Bioavailable Inhibitors of the 20S Proteasome

Pharmacokinetics, Pharmacodynamics and Anti-Tumor Efficacy of PR-171, a Novel Inhibitor of the 20S Proteasome

Electrical isolation of dislocations in Ge layers on Si(001) substrates through CMOS-compatible suspended structures

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

A CLEAR AGE-VELOCITY DISPERSION CORRELATION IN ANDROMEDA'S STELLAR DISK

The structure, function and evolution of a complete human chromosome 8

High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging

The Hubble Space Telescope Survey of M31 Satellite Galaxies. I. RR Lyrae–based Distances and Refined 3D Geometric Structure

Segmental duplications and their variation in a complete human genome

Chemobiosis reveals tardigrade tun formation is dependent on reversible cysteine oxidation

A rogues gallery of Andromeda’s dwarf galaxies – II. Precise distances to 17 faint satellites

Comparing the Quenching Times of Faint M31 and Milky Way Satellite Galaxies

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma

Aktive Filter

Suchergebnisse filtern